最近在利用针对血管生成的抗癌小分子方面取得了进展
Ying Zheng1, Hao Qiu1, Ke Zhang1
1College of Traditional Chinese Medicine and Pharmacy, Clinical Medical Research Center, Affiliated Hospital of Jinggangshan University, Jiangxi Province Key Laboratory of Organ Development and Epigenetics, Jinggangshan University, Ji'an, China.
新型小分子血管生成抑制剂通过抑制瘤生长和转移来对抗癌症显著有效. 本综述详细介绍了它们的设计和结构-活性关系,指导了未来的抗癌药物开发.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- 血管新生,新血管的形成,对于瘤生长和转移至关重要.
- 抗血管生成疗法向瘤血管系统,这是癌症治疗的关键策略.
- 最近的进展显著改善了抗血管原性癌症疗法.
研究的目的:
- 综合审查2014年至2025年间开发的小分子血管生成抑制剂.
- 分析这些抑制剂的设计,结构-活性关系 (SAR) 和作用机制.
- 为开发下一代抗血管性癌症药物提供洞察力.
主要方法:
- 对小分子血管生成抑制剂 (2014-2025) 的系统性文献综述.
- 药物设计,SAR和作用机制的分析.
- 整合该领域的最新研究成果.
主要成果:
- 许多新型血管生成抑制剂显示出显著的疗效.
- 这些抑制剂抑制血管生成,转移,并通过各种机制诱导癌细胞亡.
- 已经确定了小分子抑制剂设计和SAR的关键进展.
结论:
- 小分子血管生成抑制剂是癌症治疗的有前途的治疗策略.
- 了解它们的SAR和机制对于优化未来药物开发至关重要.
- 本综述为推进下一代抗血管性疗法提供了有价值的见解.
更多相关视频
09:03Author Spotlight: Investigating Angiogenesis and Vessel Permeability Through a Modified Matrix Gel Plug Assay
Published on: June 30, 2023
08:19Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
Published on: July 20, 2019
相关概念视频
Targeted Cancer Therapies
There are several types of targeted therapies against...
Mechanism of Angiogenesis
Regulation of Angiogenesis and Blood Supply
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer
